These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17703742)

  • 21. Design and study of lamivudine oral controlled release tablets.
    Ravi PR; Ganga S; Saha RN
    AAPS PharmSciTech; 2007 Dec; 8(4):E101. PubMed ID: 18181522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does the performance of wet granulation and tablet hardness affect the drug dissolution profile of carvedilol in matrix tablets?
    Košir D; Ojsteršek T; Vrečer F
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1543-1550. PubMed ID: 29848075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and in vitro analysis of floating matrix tablets of metronidazole using Brachystegia eurycoma gum.
    Ovenseri AC; Clifford O; Uwumagbe UM
    Pak J Pharm Sci; 2018 Jul; 31(4):1243-1249. PubMed ID: 30033407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and evaluation of mucoadhesive matrix tablets of taro gum: optimization using response surface methodology.
    Arora G; Malik K; Singh I
    Polim Med; 2011; 41(2):23-34. PubMed ID: 21866794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Native and microwave-modified Terminalia mantaly gums as sustained-release and bioadhesive excipients in naproxen matrix tablet formulations.
    Odeniyi MA; Oyedokun BM; Bamiro OA
    Polim Med; 2017; 47(1):35-42. PubMed ID: 29160627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of guar gum in the preparation of sustained-release matrix tablets.
    Khullar P; Khar RK; Agarwal SP
    Drug Dev Ind Pharm; 1998 Nov; 24(11):1095-9. PubMed ID: 9876566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and development of Albizia stipulata gum based controlled-release matrix tablets in cancer therapeutics.
    T VS; Henry LJ; Narra K; Lalduhsanga P; Kandasamy R
    Int J Biol Macromol; 2016 Nov; 92():972-980. PubMed ID: 27506120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-layer guar gum matrix tablet formulations for oral controlled delivery of highly soluble trimetazidine dihydrochloride.
    Krishnaiah YS; Karthikeyan RS; Gouri Sankar V; Satyanarayana V
    J Control Release; 2002 May; 81(1-2):45-56. PubMed ID: 11992677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rheological characterization and drug release studies of gum exudates of Terminalia catappa Linn.
    Kumar SV; Sasmal D; Pal SC
    AAPS PharmSciTech; 2008; 9(3):885-90. PubMed ID: 18661243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A three-layer guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartrate.
    Krishnaiah YS; Karthikeyan RS; Satyanarayana V
    Int J Pharm; 2002 Jul; 241(2):353-66. PubMed ID: 12100863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of oleo-gum resin as directly compressible tablet excipient and release retardant.
    Kumar P; Singh I
    Acta Pol Pharm; 2010; 67(3):307-13. PubMed ID: 20524434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled-release cellulose esters matrices for water-soluble diclofenac sodium: compression and dissolution studies.
    Obeidat WM; Alzoubi NM
    Pharmazie; 2014 Feb; 69(2):96-103. PubMed ID: 24640597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and in-vitro in-vivo evaluation of sustained release matrix diclofenac sodium tablets using PVP-K90 and natural gums.
    Iqbal Z; Khan R; Nasir F; Khan JA; Rashid A; Khan A; Khan A
    Pak J Pharm Sci; 2011 Oct; 24(4):435-43. PubMed ID: 21959802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of mucilage of Hibiscus rosasinensis Linn as rate controlling matrix for sustained release of diclofenac.
    Jani GK; Shah DP
    Drug Dev Ind Pharm; 2008 Aug; 34(8):807-16. PubMed ID: 18686091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of selected polysaccharide excipients in buccoadhesive tablets for sustained release of nicotine.
    Park CR; Munday DL
    Drug Dev Ind Pharm; 2004 Jul; 30(6):609-17. PubMed ID: 15285334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
    Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
    Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral controlled release formulations of rifampicin. Part II: Effect of formulation variables and process parameters on in vitro release.
    Hiremath PS; Saha RN
    Drug Deliv; 2008; 15(3):159-68. PubMed ID: 18379928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
    Quinten T; De Beer T; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.